Mosaic Biomedicals Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
M&A
Mosaic Biomedicals General Information
Description
Provider of cancer treatment services intended for cancer patients. The company is engaged in developing personalized cancer treatments with a dual mechanism of action to eliminate cancer stem cells and reactivate the tumor's immune system, thereby offering safer and more effective options to cancer patients across Spain.
Contact Information
Website
www.mosaicbiomedicals.comCorporate Office
- Edifici Cellex
- Carrer Natzaret 115-117
- Barcelona
- Spain
Corporate Office
- Edifici Cellex
- Carrer Natzaret 115-117
- Barcelona
- Spain
Mosaic Biomedicals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 19-Dec-2016 | Completed | Generating Revenue | |||
| 1. Seed Round | 15-May-2014 | Completed | Startup |
Mosaic Biomedicals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Mosaic Biomedicals Patents
Mosaic Biomedicals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019243900-A2 | Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer | Inactive | 18-Jun-2018 | ||
| WO-2019243900-A3 | Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer | Inactive | 18-Jun-2018 | ||
| WO-2019243898-A2 | Methods for improving response to anti-lif antibody treatment in individuals with cancer | Inactive | 18-Jun-2018 | ||
| WO-2019243898-A3 | Methods for improving response to anti-lif antibody treatment in individuals with cancer | Inactive | 18-Jun-2018 | ||
| WO-2019243898-A8 | Methods for improving response to anti-lif antibody treatment in individuals with cancer | Inactive | 18-Jun-2018 | C07K16/244 |
Mosaic Biomedicals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Mosaic Biomedicals Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Caixa Capital Risc | Corporate Venture Capital | Minority | ||
| Inveready Asset Management | Venture Capital | Minority | ||
| Versant Ventures | Venture Capital | Minority |
Mosaic Biomedicals FAQs
-
When was Mosaic Biomedicals founded?
Mosaic Biomedicals was founded in 2012.
-
Where is Mosaic Biomedicals headquartered?
Mosaic Biomedicals is headquartered in Barcelona, Spain.
-
What is the size of Mosaic Biomedicals?
Mosaic Biomedicals has 3 total employees.
-
What industry is Mosaic Biomedicals in?
Mosaic Biomedicals’s primary industry is Other Healthcare Services.
-
Is Mosaic Biomedicals a private or public company?
Mosaic Biomedicals is a Private company.
-
What is Mosaic Biomedicals’s current revenue?
The current revenue for Mosaic Biomedicals is .
-
How much funding has Mosaic Biomedicals raised over time?
Mosaic Biomedicals has raised $2.07M.
-
Who are Mosaic Biomedicals’s investors?
Caixa Capital Risc, Inveready Asset Management, and Versant Ventures have invested in Mosaic Biomedicals.
-
When was Mosaic Biomedicals acquired?
Mosaic Biomedicals was acquired on 19-Dec-2016.
-
Who acquired Mosaic Biomedicals?
Mosaic Biomedicals was acquired by Northern Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
